Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Vera Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 70
- +12 vs. Q4 2022
- Shares held
- 37.4M
- +19.0M (+103.3%) vs. Q4 2022
- Total value
- $289.7M
- −$65.7M (−18.5%) vs. Q4 2022
- New holders
- 22
- 29 more added
- Sold out
- 10
- 10 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $3.34B |
| Q1 2026 | 229 | $2.92B |
| Q4 2025 | 214 | $3.75B |
| Q3 2025 | 176 | $1.89B |
| Q2 2025 | 172 | $1.51B |
| Q1 2025 | 179 | $1.52B |
| Q4 2024 | 178 | $2.66B |
| Q3 2024 | 173 | $2.37B |
| Q2 2024 | 171 | $1.92B |
| Q1 2024 | 159 | $2.21B |
| Q4 2023 | 95 | $637.2M |
| Q3 2023 | 84 | $538.2M |
| Q2 2023 | 76 | $611.9M |
| Q1 2023 | 70 | $289.7M |
| Q4 2022 | 59 | $412.8M |
| Q3 2022 | 55 | $459.0M |
| Q2 2022 | 51 | $277.6M |
| Q1 2022 | 50 | $468.9M |
| Q4 2021 | 37 | $374.9M |
| Q3 2021 | 31 | $252.4M |
| Q2 2021 | 22 | $186.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 5,796,259 | $45.0M | 0.00% | +1,647,613+39.7% | Added |
| Sofinnova Investments, Inc. | 3,467,156 | $26.9M | 1.82% | +285,714+9.0% | Added |
| Kynam Capital Management, LP | 3,372,428 | $26.2M | 3.39% | +1,963,330+139.3% | Added |
| Carlyle Group Inc. | 2,960,231 | $22.9M | 0.68% | +2,960,231 | New |
| Commodore Capital LP | 2,824,029 | $21.9M | 3.34% | +2,824,029 | New |
| Millennium Management LLC | 1,887,351 | $14.6M | 0.02% | +778,702+70.2% | Added |
| Eversept Partners, LP | 1,788,529 | $13.9M | 1.25% | +1,377,221+334.8% | Added |
| Woodline Partners LP | 1,752,718 | $13.6M | 0.19% | +1,603,165+1,072.0% | Added |
| BlackRock Inc. | 1,410,270 | $10.9M | 0.00% | +534,386+61.0% | Added |
| Vanguard Group Inc | 1,394,851 | $10.8M | 0.00% | +627,318+81.7% | Added |
| OrbiMed Advisors LLC | 1,362,400 | $10.6M | 0.21% | +1,362,400 | New |
| Deerfield Management Company, L.P. (Series C) | 1,300,000 | $10.1M | 0.22% | +1,300,000 | New |
| Point72 Asset Management, L.P. | 1,037,128 | $8.05M | 0.03% | +1,037,128 | New |
| International Biotechnology Trust PLC | 1,002,257 | $7.75M | 2.16% | +721,000+256.3% | Added |
| Octagon Capital Advisors LP | 795,000 | $6.17M | 0.89% | +129,844+19.5% | Added |
| Citadel Advisors LLC | 775,792 | $6.02M | 0.01% | −1,215,681−61.0% | Reduced |
| Sectoral Asset Management Inc | 600,300 | $4.66M | 0.90% | +600,300 | New |
| Geode Capital Management, LLC | 480,045 | $3.73M | 0.00% | +222,979+86.7% | Added |
| Baker Bros. Advisors LP | 333,333 | $2.59M | 0.01% | 00.0% | Unchanged |
| State Street Corp | 304,147 | $2.36M | 0.00% | +47,451+18.5% | Added |
| Alphabet Inc. | 301,580 | $2.34M | 0.13% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 300,000 | $2.33M | 0.04% | −114,000−27.5% | Reduced |
| Altium Capital Management LP | 286,000 | $2.22M | 1.33% | +286,000 | New |
| UBS Oconnor LLC | 223,468 | $1.73M | 0.04% | +223,468 | New |
| Northern Trust Corp | 193,385 | $1.50M | 0.00% | +67,904+54.1% | Added |
| Renaissance Technologies LLC | 174,800 | $1.36M | 0.00% | +149,900+602.0% | Added |
| Cubist Systematic Strategies, LLC | 159,914 | $1.24M | 0.01% | +159,914 | New |
| Bank of New York Mellon Corp | 97,980 | $760.3K | 0.00% | +26,210+36.5% | Added |
| Bank of America Corp | 87,837 | $681.6K | 0.00% | +36,161+70.0% | Added |
| State of Wisconsin Investment Board | 84,000 | $651.8K | 0.00% | +69,844+493.4% | Added |
| Nuveen Asset Management, LLC | 78,939 | $612.0K | 0.00% | −19,197−19.6% | Reduced |
| Squarepoint Ops LLC | 66,116 | $513.1K | 0.00% | +66,116 | New |
| Charles Schwab Investment Management Inc | 61,419 | $476.6K | 0.00% | +22,560+58.1% | Added |
| Jump Financial, LLC | 52,700 | $409.0K | 0.02% | +35,100+199.4% | Added |
| Two Sigma Investments, LP | 47,014 | $364.8K | 0.00% | +29,997+176.3% | Added |
| Marshall Wace, LLP | 44,786 | $347.5K | 0.00% | +44,786 | New |
| Morgan Stanley | 40,668 | $315.6K | 0.00% | +25,115+161.5% | Added |
| Crestline Management, LP | 29,367 | $227.9K | 0.03% | +29,367 | New |
| Susquehanna International Group, LLP | 29,350 | $227.8K | 0.00% | +29,350 | New |
| Alps Advisors Inc | 27,629 | $214.4K | 0.00% | +8,880+47.4% | Added |
| Rhumbline Advisers | 27,294 | $212.0K | 0.00% | +9,241+51.2% | Added |
| Raymond James & Associates | 25,285 | $196.2K | 0.00% | +25,285 | New |
| Jane Street Group, LLC | 19,299 | $149.8K | 0.00% | +19,299 | New |
| Raymond James Financial Services Advisors, Inc. | 17,828 | $138.3K | 0.00% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 17,816 | $138.3K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 16,642 | $129.0K | 0.00% | −97,340−85.4% | Reduced |
| Gsa Capital Partners LLP | 16,272 | $126.0K | 0.01% | +16,272 | New |
| Carnegie Mellon University | 16,060 | $124.6K | 0.08% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 14,384 | $112.0K | 0.00% | +14,384 | New |
| Deutsche Bank AG | 13,950 | $108.3K | 0.00% | +7,602+119.8% | Added |
| XTX Topco Ltd | 11,815 | $91.7K | 0.02% | +11,815 | New |
| New York State Common Retirement Fund | 11,013 | $85.5K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 10,972 | $85.1K | 0.00% | −2,307−17.4% | Reduced |
| American International Group, Inc. | 10,476 | $81.3K | 0.00% | +3,698+54.6% | Added |
| Virtu Financial LLC | 10,481 | $81.0K | 0.01% | +10,481 | New |
| Walleye Capital LLC | 10,100 | $78.4K | 0.00% | −219,104−95.6% | Reduced |
| Sandia Investment Management LP | 10,000 | $77.6K | 0.01% | +10,000 | New |
| Cambridge Trust Co | 9,887 | $76.7K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 9,492 | $73.0K | 0.00% | +9,492 | New |
| UBS Group AG | 8,933 | $69.3K | 0.00% | +8,036+895.9% | Added |
| MetLife Investment Management | 8,881 | $68.9K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 8,070 | $62.6K | 0.00% | −10,627−56.8% | Reduced |
| Tower Research Capital LLC (TRC) | 4,834 | $38.0K | 0.00% | +4,303+810.4% | Added |
| Wells Fargo & Company | 4,207 | $32.6K | 0.00% | +4,207 | New |
| Legal & General Group Plc | 2,579 | $20.0K | 0.00% | −3,327−56.3% | Reduced |
| Amalgamated Bank | 2,595 | $20.0K | 0.00% | +392+17.8% | Added |
| Royal Bank of Canada | 1,714 | $13.0K | 0.00% | −819−32.3% | Reduced |
| Metropolitan Life Insurance Co | 1,328 | $10.3K | 0.00% | +287+27.6% | Added |
| Ameritas Investment Partners, Inc. | 1,061 | $8.23K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 11 | $0 | 0.00% | −6−35.3% | Reduced |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −400,666−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −285,000−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −35,900−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −35,372−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −11,498−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −10,945−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −9,558−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −9,413−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −467−100.0% | Sold out |
| Abingworth LLP | – | – | – | – | Not filed |